Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,519.5
-10.8 (-0.43%)

 

  • STI Straits Times Index
    2,519.5
    -10.8 (-0.43%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,451.7
    15.0 (1.04%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,301.4
    -83.3 (-0.36%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,836.8
    -9.7 (-0.34%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,419.2
    148.1 (0.70%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,641.6
    14.8 (0.32%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,345.0M
  • Value: 1,392.6M
  • Rise: 148
  • Fall: 146
  • Unch: 514

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Reenova Investment^0.003+0.001
Medtecs Intl0.235+0.045
Rex Intl0.143-0.001
UG Healthcare0.450+0.080
Clearbridge0.200+0.016
Singtel2.620-0.040
Singapore-eDev0.056+0.003
ComfortDelGro1.530-
Genting Sing0.780+0.020
Mapletree Log Tr1.900+0.010

World Indices

World Indices
Name Last Change
Nasdaq 9,340.2 +15.6
HSI 23,301.4 -83.3
HSCEI 9,567.4 -27.8
Jakarta 4,641.6 +14.8
Nikkei 225 21,419.2 +148.1
SSE Comp 2,836.8 -9.7
Shanghai A 2,973.3 -10.2
Shanghai B 207.0 -1.1
KOSPI 2,031.2 +1.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ALIMERA SCIENCES INC ALIMERA SCIENCES
Updated on 26 May 2020 (End of trading day)
Last (USD): 5.390 Change: +0.030 High: 5.460 Remarks: -
Change (%): +0.56 Low: 5.260
Open 5.378 Yesterday's Close 5.359999999999999
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 3,014 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -2.07543 Trailing EPS (USD) e -1.76440 NAV (USD) b -7.1045
PE a - Trailing PE f - Price / NAV b -0.7587
Dividend (USD) d - Cash In Hand (USD) g 2.4391 Issued & Paid-up Shares c 5,031,740
Dividend Yield (%) d - Price / Cash In Hand g 2.210 Treasury Shares h -
Beta - 75 Daysi 1.029 R-Squared - 75 Days(%)i 19.48 Market Cap (M) 27.121
Beta - 500 Daysi 1.471 R-Squared - 500 Days (%)i 0.14 Enterprise Value (M) 88.065
Piotroski F Score 1 Exchange Code ALIM Par Value ( $ ) n.a.
52 Weeks Volatility (%) 107.76 Free Float (%) 80.5
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 06 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ALIMERA SCIENCES INC NASDAQ 27.121 - - -0.7587 -
Industry Biotechnology NASDAQ 2,715.539 354.285 68678.556 6.6771 0.706
Local Peer AMGEN INC NASDAQ 130,826.133 16.683 17.046 13.7929 2.622
Local Peer GILEAD SCIENCES INC NASDAQ 91,767.720 17.038 18.494 4.1586 3.477
Local Peer VERTEX PHARMACEUTICAL NASDAQ 69,097.321 58.716 45.732 10.6934 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 61,348.103 28.995 26.915 5.0563 -
Local Peer ILLUMINA INC NASDAQ 52,098.270 51.994 55.306 11.2402 -
Local Peer BIOGEN INC NASDAQ 48,282.138 8.199 8.213 3.8481 -
Local Peer SEATTLE GENETICS INC NASDAQ 26,264.766 - - 14.8756 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,701.016 9.442 9.562 1.9324 -
Local Peer INCYTE CORPORATION NASDAQ 21,450.368 47.998 - 11.0699 -
Local Peer MODERNA INC NASDAQ 21,423.337 - - 13.0560 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 18,760.030 - 164.553 5.7902 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 15,426.413 - - 11.4293 -
Other Local Peers GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), UNIQURE N.V. (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), INSMED INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ALKERMES PLC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), EPIZYME INC (NASDAQ), XENCOR INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), REGENXBIO INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), EDITAS MEDICINE INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), CORTEXYME INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), VERACYTE INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), CYTOKINETICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), MACROGENICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), NEXTCURE INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), OMEROS CORP (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AVROBIO INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), RETROPHIN INC (NASDAQ), ARDELYX INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), RADIUS HEALTH INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), NANTKWEST INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), MERUS B V (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), XBIOTECH INC (NASDAQ), PRECIGEN INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), PERSONALIS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), KAMADA (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), GERON CORP (NASDAQ), MANNKIND CORPORATION (NASDAQ), AVID BIOSERVICES INC (NASDAQ), VERASTEM INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), CHIASMA INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), VERMILLION INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), AFFIMED N V (NASDAQ), MEDICINOVA INC (NASDAQ), XOMA CORP (NASDAQ), CHIMERIX INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), IVERIC BIO INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), VAXART INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ARAVIVE INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), IMV INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), ORGENESIS INC (NASDAQ), TREVENA INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), CABALETTA BIO INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), GLYCOMIMETICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), SAVARA INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), LUMOS PHARMA INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), COHBAR INC (NASDAQ), RECRO PHARMA INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), SESEN BIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), RESTORBIO INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), OTONOMY INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), INMUNE BIO INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), VACCINEX INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), SOLIGENIX INC (NASDAQ), EQUILLIUM INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ZAFGEN INC (NASDAQ), ADVAXIS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ATYR PHARMA INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), TOCAGEN INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CURIS INC (NASDAQ), BIOCARDIA INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), EVOGENE LTD (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), AIKIDO PHARMA INC (NASDAQ), OCUGEN INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PRECIPIO INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ)
Global Peer CSL ASX 130,766.112 48.740 45.142 15.1203 0.921
Global Peer AMGEN-T HKEx 588,247.000 9.574 9.804 8.0015 4.569
Global Peer AGILENT TECHNOLOGIES INC NYSE 26,670.241 24.902 39.049 5.5936 0.760
Global Peer WUXI BIO HKEx 160,318.674 139.460 139.460 11.2107 -
Global Peer SINO BIOPHARM HKEx 149,533.718 48.719 48.720 4.2968 0.670
Global Peer BEIGENE HKEx 97,546.323 - - 4.4752 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 4,404.459 80.816 64.676 4.0979 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer GENSCRIPT BIO HKEx 31,747.829 - - 10.6440 -
Global Peer 3SBIO HKEx 22,795.730 20.646 20.646 2.1173 -
Other Global Peers ALPHAMAB-B (HKEx), ARCUS BIOSCIENCES INC (NYSE), VIVA BIOTECH (HKEx), MESOBLAST LTD (ASX), HAOHAI BIOTEC (HKEx), POLYNOVO LIMITED (ASX), MYOVANT SCIENCES LTD (NYSE), FRONTAGE (HKEx), KINTOR PHARMA-B (HKEx), ASCENTAGE-B (HKEx), KADMON HLDGS INC (NYSE), AVITA MEDICAL LTD (ASX), SINOMAB BIO-B (HKEx), NANOVIRICIDES INC (NYSE American), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), LEE'S PHARM (HKEx), DPHARMA (Bursa), BBI LIFE SCI (HKEx), TELIX PHARMACEUTIC (ASX), NEXT SCIENCE LTD (ASX), PFENEX INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), IBIO INC (NYSE American), ENZO BIOCHEM INC (NYSE), CEL-SCI CORP (NYSE American), UNI-BIO GROUP (HKEx), NEUREN PHARMACEUTICALS LTD (ASX), IMUGENE LIMITED (ASX), 22ND CENTURY GROUP INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), IMMUTEP LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), BIOTRON (ASX), CT ENTERPRISE (HKEx), MEMPHASYS LTD (ASX), BIOSINO BIO-TEC (HKEx), HOLISTA COLLTECH LIMITED (ASX), ORAGENICS INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), ANTEOTECH LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), CCP TECHNOLOGIES LTD (ASX), Suntar Eco-City^ (SGX), BIONOMICS LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), SIENNA CANCER DIAGNOSTICS LTD (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), REGENT PACIFIC (HKEx), REGENEUS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), ACTINOGEN MEDICAL LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), RHINOMED LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), PATRYS LIMITED (ASX), ADALTA LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), HAO WEN HLDGS (HKEx), AMPLIA THERAPEUTICS LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), LEAF RESOURCES LTD (ASX), CRYOSITE (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.110
+2.08 %
10 Days -+0.380
+7.58 %
20 Days -+0.300
+5.89 %
Medium Term Return 3 Months --0.620
-10.32 %
6 Months --0.190
-3.41 %
1 Year --7.657
-58.69 %
Long Term Return 2 Years --6.324
-53.99 %
3 Years --15.910
-74.69 %
5 Years --60.610
-91.83 %
Annualised Return Annualised --
-39.41 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.004 - 15.450 Change From 1 Year Low +5.386 % Change From 1 Year Low (%) +119677.78
Change From 1 Year High -10.060 % Change From 1 Year High (%) -65.11
2 Years Range 0.004 - 18.150 Change From 2 Years Low +5.386 % Change From 2 Years Low (%) +119677.78
Change From 2 Years High -12.760 % Change From 2 Years High (%) -70.30
5 Years Range 0.004 - 77.250 Change From 5 Years Low +5.386 % Change From 5 Years Low (%) +119677.78
Change From 5 Years High -71.860 % Change From 5 Years High (%) -93.02
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It operates through the U.S. and International geographic segments. The firm focuses on the development of ophthalmic pharmaceuticals for the treatment of diabetic macular edema, wet and dry age-related macular degeneration, and retinal vein occlusion. Its products include ILUVIEN and NADPH Oxidase Inhibitors. The company was founded by Daniel C. Myers and David R. Holland on June 4, 2003 and is headquartered in Alpharetta, GA.

Historical Price Data

Date Open High Low Close Volume VWAP
26 May 2020 5.378 5.460 5.260 5.390 3,014 -
22 May 2020 5.240 5.400 5.240 5.360 2,108 -
21 May 2020 5.390 5.430 5.130 5.130 2,691 -
20 May 2020 5.410 5.720 5.280 5.280 9,533 -
19 May 2020 5.670 5.670 5.130 5.460 12,880 -
18 May 2020 5.607 5.680 5.513 5.650 4,752 -
15 May 2020 5.490 5.530 4.970 5.390 6,360 -
14 May 2020 5.260 5.420 5.040 5.395 3,859 -
13 May 2020 5.462 5.608 4.770 5.010 20,015 -
12 May 2020 5.670 5.920 5.300 5.310 24,544 -
11 May 2020 5.800 6.000 5.680 5.680 6,945 -
08 May 2020 5.780 5.980 5.600 5.810 31,526 -
07 May 2020 5.560 5.965 5.480 5.820 3,472 -
06 May 2020 5.340 5.610 5.340 5.600 5,798 -
05 May 2020 5.750 5.750 5.235 5.658 22,341 -
04 May 2020 5.389 5.930 5.389 5.720 5,004 -
01 May 2020 5.450 6.010 5.450 5.560 13,379 -
30 Apr 2020 5.470 6.400 5.170 5.400 72,136 -
29 Apr 2020 5.290 5.500 4.970 5.090 25,595 -
28 Apr 2020 5.130 5.133 4.830 5.100 11,732 -
27 Apr 2020 4.713 5.202 4.532 5.120 23,795 -
24 Apr 2020 4.710 4.740 4.627 4.712 4,320 -
Summary
Current 2 Weeks
(12 May 2020 to 26 May 2020)
5.670 5.920 4.770 5.390 89,756 -
Previous 2 Weeks
(28 Apr 2020 to 11 May 2020)
5.130 5.920 4.770 5.680 197,928 -
4 Weeks from
(30 Mar 2020 to 27 Apr 2020)
4.449 5.920 3.580 5.120 319,218 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.